The project was headed up Nancy Thornberry, a biologist, and Ann Weber, a chemist (figure 34)
The gut-brain axis plays a significant role in digestive and hormonal regulation, and psychological wellbeing may indirectly affect gut hormone production
The future of retatrutide in bodybuilding will be shaped by Phase 3 trial results, potential FDA approval (which would improve quality and accessibility), and the growing body of real-world experience from physique athletes who are pioneering its use
The AACE 2023 consensus statement on obesity pharmacotherapy echoes this position, noting that "escalation within a single mechanism class should be exhausted before combination strategies are considered" [5]
While most people recognize GLP-1 medications as weekly injections, we understand that many patients are needle-shy
Retatrutide has not been approved for human use in the UK, and reconstitution and administration outside of a formal, ethics-approved clinical trial is not sanctioned by any UK regulatory body
